Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05300230
Other study ID # FIS-ZTI-2019-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 15, 2020
Est. completion date November 15, 2022

Study information

Verified date March 2022
Source Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Contact Amparo Callejón Leblic
Phone 955 00 80 00
Email amparocallejon@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to establish the connection between the cochlear implant programming parameters with the auditory effort associated with the speech perception evaluated by pupillometry techniques in different audiometric conditions.


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date November 15, 2022
Est. primary completion date July 15, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Users willing to participate in the study with signature and date of the Informed Consent. - Age between 18 and 70 years old. - At least 6 months experience with the Neuro Zti implant and Neuro 2 processor. - Unilateral, bilateral and bimodal users. - Basic understanding of oral and written Spanish. - Normal or corrected vision. Exclusion Criteria: - Speech or language disorder. - Added comorbidities or cognitive dysfunction. - Not approval to participate in the study or absence in some of the programmed sessions for the Cochlear Implant.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Neuro Zti cochlear implant and Neuro 2 sound processor
The study will consist in 3 visits: Visit 1: it will be carried out the first contact and learning the measurement procedure. Visit 2: it will be evaluated the speech perception and the measurement of the pupil dilatation in silence and noise conditions. Visit 3: it will be analysed the effect of the change in the cochlear implant programming parameters.

Locations

Country Name City State
Spain Hospital Universitario Virgen Macarena Sevilla

Sponsors (1)

Lead Sponsor Collaborator
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Analyze the correlation between the speech performance in cochlear implant (CI) users, as measured through the percentage of sentence recognition (%) and the auditory effort, measured by peak pupil dilatation (PPD) in mm. The speech perception will be evaluated through validated sentence recognition tests (such as the HINT test) and the result will be the percentage of correct sentences repeated by the CI patient. The listening effort will be measured through pupillometry techniques in scenarios with different audiometric conditions (different SNR). The result will be the peak pupil dilation in mm. Up to 12 months after the beginning of the study
Secondary Evaluate the correlation between the auditory effort as measured through pupillometry techniques and the subjective sensation of the CI patient as rated through validated NASA-TLX questionnaire. Analyze the correlation between the objetive auditory effort as measured through pupillometry techniques (peak pupil dilatation, PPD in mm) and the subjetive feeling of effort (fatigue, etc.) as rated by the CI patient in NASA-TLX questionnaire. Up to 12-24 months after the beginning of the study
Secondary Evaluate the correlation between the auditory effort as measured through pupillometry techniques and the cognitive performance of the CI user as measured by different cognitive tests (Nback, Progressive Matrices, Stroop). Analyze the correlation between the objetive auditory effort as measured through pupillometry techniques (peak pupil dilatation, PPD in mm) and the cognitive performance of the CI patient as measured through cognitive tests (Nback, Progressive Matrices, Stroop) Up to 12-24 months after the beginning of the study
Secondary Analyze the differences between the auditory effort, as measured through pupillometry techniques in two different CI programming conditions. Compare the auditory effort made by the CI patients, as measured by pupillometry techniques, i.e., the peak pupil dilatation (PPD in mm) over two different CI programming conditions: the first condition with the noise filter capability of the CI processor in off mode (VoiceTrack OFF) and the second condition with the noise filters in ON mode (VoiceTrack ON) Up to 12-36 months after the beginning of the study
See also
  Status Clinical Trial Phase
Recruiting NCT05438264 - Effect of Donepezil on Speech Recognition in Cochlear Implant Users Early Phase 1
Recruiting NCT05962359 - Neural Prediction to Enhance Language N/A
Completed NCT02075229 - Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS Population